Mucormycosis is a life-threatening fungal infection. It occurs predominantly in individuals with diabetes, in particular those with the potentially life-threatening complication known as diabetic ketoacidosis. New data, generated in mice, provide an explanation as to why patients with DKA are highly susceptible to mucormyosis and suggest a new avenue of research for those developing therapeutics for this life-threatening infection.